Recently recognized as an additional biomarker for the diagnosis of T1DM, ZnT8 was identified through bioinformatics based on the common features including, enhanced β-cell expression, alternative splicing, and association with the secretory pathway. Here, SLC30A8 is linked to type 1 diabetes mellitus.